Discovery and Characterization of BAY-184: A New Potent and Selective Acylsulfonamide-Benzofuran <i>In Vivo</i>-Active KAT6AB Inhibitor

KAT6A and KAT6B genes are two closely related lysine acetyltransferases that transfer an acetyl group from acetyl coenzyme A (AcCoA) to lysine residues of target histone substrates, hence playing a key role in chromatin regulation. KAT6A and KAT6B genes are frequently amplified in various cancer types. In breast cancer, the 8p11-p12 amplicon occurs in 12-15% of cases, resulting in elevated copy numbers and expression levels of chromatin modifiers like KAT6A. Here, we report the discovery of a new acylsulfonamide-benzofuran series as a novel structural class for KAT6A/B inhibition. These compounds were identified through high-throughput screening and subsequently optimized using molecular modeling and cocrystal structure determination. The final tool compound, BAY-184 (<b>29</b>), was successfully validated in an <i>in vivo</i> proof-of-concept study.

Authors

Institutions

Publication Details

Journal
Journal of Medicinal Chemistry
Published
2024-10-25
DOI
https://doi.org/10.1021/acs.jmedchem.4c01709
Citations
8
Primary Topic
Phosphodiesterase function and regulation
Type
article
Field-Weighted Citation Impact
1.87

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Discovery and Characterization of BAY-184: A New Potent and Selective Acylsulfonamide-Benzofuran In Vivo-Active KAT6AB Inhibitor

Ingo V. Hartung, Stefan Gradl, Christoph A. Schatz, Katrin Nowak‐Reppel et al.
8 citations
Journal of Medicinal Chemistry
Phosphodiesterase function and regulation
1.87
article

Discovery and Characterization of BAY-184: A New Potent and Selective Acylsulfonamide-Benzofuran In Vivo-Active KAT6AB Inhibitor

Ingo V. Hartung, Stefan Gradl, Christoph A. Schatz, Katrin Nowak‐Reppel, Naomi Barak, Volker Badock, Léa Bouché, Wilhelm Bone, Simon A. Herbert, Roland Neuhaus, Vera Puetter, Antonius ter Laak, Steven Ferrara, R.C. Hillig, Franziska Siegel, Matthew Meyerson, Craig A. Strathdee, Mátyás Gorjánácz, Amaury E. Fernández‐Montalván, Philip Lienau, Olaf Doehr, Daniel Korr
article en
8 citations

Abstract

KAT6A and KAT6B genes are two closely related lysine acetyltransferases that transfer an acetyl group from acetyl coenzyme A (AcCoA) to lysine residues of target histone substrates, hence playing a key role in chromatin regulation. KAT6A and KAT6B genes are frequently amplified in various cancer types. In breast cancer, the 8p11-p12 amplicon occurs in 12-15% of cases, resulting in elevated copy numbers and expression levels of chromatin modifiers like KAT6A. Here, we report the discovery of a new acylsulfonamide-benzofuran series as a novel structural class for KAT6A/B inhibition. These compounds were identified through high-throughput screening and subsequently optimized using molecular modeling and cocrystal structure determination. The final tool compound, BAY-184 (<b>29</b>), was successfully validated in an <i>in vivo</i> proof-of-concept study.

Journal of Medicinal ChemistryVol. 67(21)
Broad Institute (US), Bayer (Germany) (DE)
Bayer, Broad Institute
Life below water
Openalex Percentile: Top 14%
Phosphodiesterase function and regulation
1.87
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.